DLL3 and small cell lung carcinoma: Importantly, to our knowledge, this is the first study to simultaneously investigate both PDL1 and DLL3 biomarkers in endobronchial biopsies while exploring their correlation with clinical characteristics and overall survival in SCLC patients.